IMR Press / FBS / Special Issues / end_goal_immunogenetics

The End Goal of Immunogenetics: Clinical Applications and Personalized Medicine

Submission deadline: 10 February 2023
Special Issue Editors
  • Anna Aiello, PhD
    Laboratory of Immunopathology and Immunosenescence, Department of Biomedicine, Neuroscience and Advanced Diagnostic, University of Palermo, Palermo, Italy
    Interests: immunogenetics; viral infections; inflammation; inflamm-aging; immunosenescence; aging; positive biology; longevity; centenarians; nutrigerontology; nutrition
  • Mattia Emanuela Ligotti, PhD
    Laboratory of Immunopathology and Immunosenescence, Department of Biomedicine, Neuroscience and Advanced Diagnostic, University of Palermo, Palermo, Italy
    Interests: immunogenetics; viral infections; inflamm-aging; immunosenescence; immunophetotyping; aging; longevity; ultracentenarians
Special Issue Information

Dear Colleagues,

Research on personalized medicine is a major priority for healthcare systems as a strategy aimed at delivering specific health and care solutions. There is no commonly agreed definition for the term ‘personalized medicine’. It is widely recognized that personalized medicine refers to a medical model that strives for a personalized therapeutic strategy through the characterization of an individual’s phenotype and genotype (e.g., molecular profiling, medical imaging, lifestyle data). This could help to determine disease susceptibility and to target specific prevention strategies.

In this regard, the end goal of the Immunogenetic investigation is to understand and identify the specific genes responsible for encoding cells and the specific molecules involved in immune responses.

These studies would allow the identification of genetic and molecular causes underlying a plethora of immune-related disorders, which is essential for the formulation of targeted therapeutic strategies. This approach is critical in considering that such genetic abnormalities may result in the inability to appropriately counteract pathogenic infections or predisposition to autoimmune disorders or cancer. This Special Issue will collect and present reviews and original studies in an attempt to expand our knowledge on the interconnection between Immunogenetics and personalized medicine, in order to further support researchers and clinicians.

Papers should include and develop the following topics:
• The role of Immunogenetics in the control of viruses and/or other immune-related diseases;
• Original papers regarding immunological responses to viruses and/or in other human disorders to elucidate basic mechanisms involved in immunity along with those affecting immune tolerance, dysregulation and disease;
• Clinical application of Immunogenetics studies such as gene therapy.

Dr. Anna Aiello and Dr. Mattia Emanuela Ligotti

Guest Editors

Keywords
immunogenetics
immuno-related diseases
immune dysregulation
clinical
gene therapy
personalized medicine
translational medicine
Manuscript Submission Information

Manuscripts should be submitted via our online editorial system at https://imr.propub.com by registering and logging in to this website. Once you are registered, click here to start your submission. Manuscripts can be submitted now or up until the deadline. All papers will go through peer-review process. Accepted papers will be published in the journal (as soon as accepted) and meanwhile listed together on the special issue website. Research articles, reviews as well as short communications are preferred. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office to announce on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts will be thoroughly refereed through a double-blind peer-review process. Please visit the Instruction for Authors page before submitting a manuscript. The Article Processing Charge (APC) in this open access journal is 500 USD. Submitted manuscripts should be well formatted in good English.

Back to top